These FDMCA-nanoparticles loaded with macrophage inflammatory protein three β (MIP-3β), as an enhancer for anti-cancer, demonstrated up-regulated of MIP-3β in cancer cells and exhibited DC cell maturation, induced M1 phenotype, and activation lymphocytes. Here, CCL19 is linked to cancer.